https://www.selleckchem.com/products/go-203.html
90; 95% CI 0.77-1.05, P = 0.17, cT2a (OR = 0.90; 95% CI 0.69-1.19, P = 0.454), or cT2b (OR = 0.96; 95% CI 0.62-1.51, P = 0.873). In all clinical stage strata, nonclear cell RCCs were significantly less likely to be upstaged (P 0.001). A sensitivity analysis, performed for delays of 1, 1-3, 3-6, and 6 months, also showed no increase in upstaging risk. Delaying surgery up to, and even beyond, 3 months does not significantly increase risk of tumor progression in clinically localized RCC. However, if deciding to delay surgery d
Like
Comment
Share
